Click to zoom
Product Description
OLANAMO-150 contains Olaparib (150 mg), a targeted PARP inhibitor used to treat advanced ovarian, breast, pancreatic, and prostate cancers with specific genetic mutations (like BRCA). The standard adult dosage is 300 mg (two 150 mg tablets) taken orally twice daily.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Composition
Strength 150 mg
Dose/Strength 150 mg
Brand Olanamo
Tablets per Pack 56 Tablets
Usage Cancer Care
Pack Type Bottle
Packaging Type Bottle
Packaging Size 1*120 Tablets
Country of Origin Made in India
Form Tablet
Minimum order quantity: 50 Box
Shipping Information
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.
500 mg CIPRODAC 500 CIPROFLOXACIN IP TABLETS
On Request
500 mg Ciplox-500 Ciprofloxacin Hydrochloride IP Tablets
On Request
12 mg Iverheal 12 Ivermectin Dispersible Tablets
On Request
500 mg Novamox-500 Amoxycillin Trihydrate IP Capsules
On Request
500 mg Methoflam-500 Methocarbamol IP Tablets
On Request
25 mg Baclosign-25 Baclofen Tablets
On Request
25 mg LENANAMO Lenalidomide Capsules
On Request
500 mg Captomer MERCAPTOPURINE I.P. TABLETS
On Request